Back
Las Vegas Sands Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
80
LVS
Las Vegas Sands
Last Price:
51.12
Seasonality Move:
4.03%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
Buy
80
Las Vegas Sands (LVS)
is a Buy
Is Las Vegas Sands a Buy, Sell or Hold?
- The current Las Vegas Sands [LVS] share price is $51.12. The Score for LVS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- LVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVS Stock Price Chart
What is Las Vegas Sands's stock price today?
-
The Las Vegas Sands share price today is $51.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
LVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.9 | Buy |
Relative Strength Index (14 RSI): | 86.14 | Buy |
Chaikin Money Flow: | 10571647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.29 - 44.23) | Buy |
Bollinger Bands (100): | (39.6 - 45.2) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.58 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | 227264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (257.28 - 277.8) | Buy |
Bollinger Bands (100): | (173.47 - 275.75) | Buy |
LVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.47 | Buy |
20-day SMA: | 41.63 | Buy |
50-day SMA: | 40.49 | Buy |
200-day SMA: | 46.41 | Buy |
8-day EMA: | 45.48 | Buy |
20-day EMA: | 42.83 | Buy |
50-day EMA: | 41.75 | Buy |
200-day EMA: | 45.09 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 273.53 | Buy |
20-day SMA: | 264.94 | Buy |
50-day SMA: | 262.48 | Buy |
200-day SMA: | 194.67 | Buy |
8-day EMA: | 272.54 | Buy |
20-day EMA: | 269.21 | Buy |
50-day EMA: | 257.72 | Buy |
200-day EMA: | 211.82 | Buy |
Las Vegas Sands Earnings Growth & LVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.18 per share, an increase this year of $0.56 per share, and an increase next year of $0.34 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Las Vegas Sands Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |